Free Trial

Braskem (NYSE:BAK) Shares Down 5.4% - Time to Sell?

Braskem logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Shares fell 5.4% intraday to $3.4150 on Monday, with 829,477 shares traded—about 65% below the average daily volume.
  • Analyst sentiment has soured to a consensus "Reduce" (four Holds, three Sells); notable moves include Citigroup upgrading to Hold while Bank of America downgraded to Underperform with a $2.80 target and a $3.87 average price target.
  • Fundamentals are weak: market cap ~$1.32B, last-quarter EPS of ($2.33), negative net margin (−14.53%) and ROE (−21.95%), and analysts forecast roughly −0.77 EPS for the current fiscal year.
  • Five stocks we like better than Braskem.

Braskem S.A. (NYSE:BAK - Get Free Report)'s stock price traded down 5.4% on Monday . The stock traded as low as $3.43 and last traded at $3.4150. 829,477 shares traded hands during mid-day trading, a decline of 65% from the average session volume of 2,400,646 shares. The stock had previously closed at $3.61.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on BAK. Weiss Ratings restated a "sell (e+)" rating on shares of Braskem in a report on Wednesday, January 21st. Citigroup upgraded Braskem from a "strong sell" rating to a "hold" rating in a research note on Wednesday, April 1st. Zacks Research downgraded Braskem from a "strong-buy" rating to a "hold" rating in a research report on Monday, January 19th. Finally, Bank of America downgraded shares of Braskem from a "neutral" rating to an "underperform" rating and set a $2.80 price target for the company. in a report on Thursday, March 26th. Four investment analysts have rated the stock with a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, Braskem currently has a consensus rating of "Reduce" and an average price target of $3.87.

View Our Latest Stock Report on Braskem

Braskem Price Performance

The firm has a market capitalization of $1.32 billion, a PE ratio of -0.72 and a beta of 1.74. The company's fifty day simple moving average is $3.97 and its 200 day simple moving average is $3.23.

Braskem (NYSE:BAK - Get Free Report) last announced its earnings results on Saturday, February 14th. The company reported ($2.33) earnings per share for the quarter. The company had revenue of $2.56 billion during the quarter. Braskem had a negative net margin of 14.53% and a negative return on equity of 21.95%. On average, analysts anticipate that Braskem S.A. will post -0.77 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Braskem

Hedge funds have recently added to or reduced their stakes in the stock. Millennium Management LLC bought a new position in shares of Braskem during the 4th quarter valued at $112,000. Schonfeld Strategic Advisors LLC purchased a new stake in Braskem in the 4th quarter worth $232,000. Squarepoint Ops LLC purchased a new position in Braskem in the 4th quarter worth approximately $79,000. Marshall Wace LLP bought a new position in shares of Braskem during the fourth quarter worth $477,000. Finally, State Street Corp grew its holdings in Braskem by 7.2% during the 4th quarter. State Street Corp now owns 311,507 shares of the company's stock valued at $919,000 after buying an additional 20,805 shares in the last quarter.

Braskem Company Profile

(Get Free Report)

Braskem NYSE: BAK is a leading integrated petrochemical company based in São Paulo, Brazil, and holds the distinction of being the largest thermoplastic resins producer in Latin America. The company operates across the entire value chain, from feedstock sourcing and polymer production to distribution and recycling. Braskem's comprehensive approach to petrochemical manufacturing enables it to serve a diverse set of end markets with a broad portfolio of products.

Braskem's core product lines include polypropylene, polyethylene and polyvinyl chloride (PVC), which are used in industries such as packaging, automotive, construction and electrical & electronics.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Braskem Right Now?

Before you consider Braskem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Braskem wasn't on the list.

While Braskem currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines